Bleeding Avoidance Strategies: Consensus and Controversy
- 28 June 2011
- journal article
- review article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 58 (1), 1-10
- https://doi.org/10.1016/j.jacc.2011.02.039
Abstract
No abstract availableKeywords
Funding Information
- NIH (R01 LM008142-04)
- The Medicines Company
- Abbott Vascular
- St. Jude
- Terumo
This publication has 104 references indexed in Scilit:
- Safety of immediate reversal of anticoagulation by protamine to reduce bleeding complications after infarct artery stenting for acute myocardial infarction and adjunctive abciximab therapyJournal of Thrombosis and Thrombolysis, 2010
- Has the frequency of bleeding changed over time for patients presenting with an acute coronary syndrome? The Global Registry of Acute Coronary EventsEuropean Heart Journal, 2009
- Vascular Closure Device Failure: Frequency and ImplicationsCirculation: Cardiovascular Interventions, 2009
- Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: A subgroup analysis from the SYNERGY trialCatheterization and Cardiovascular Interventions, 2009
- Intracoronary versus intravenous abciximab in ST-segment elevation myocardial infarction: rationale and design of the CICERO trial in patients undergoing primary percutaneous coronary intervention with thrombus aspirationTrials, 2009
- Periprocedural Bleeding and 1-Year Outcome After Percutaneous Coronary Interventions: Appropriateness of Including Bleeding as a Component of a Quadruple End PointYearbook of Cardiology, 2009
- Variation in the definitions of bleeding in clinical trials of patients with acute coronary syndromes and undergoing percutaneous coronary interventions and its impact on the apparent safety of antithrombotic drugsAmerican Heart Journal, 2007
- A propensity analysis of the risk of vascular complications after cardiac catheterization procedures with the use of vascular closure devicesAmerican Heart Journal, 2007
- A Cost-Minimization Analysis of the Angio-Seal Vascular Closure Device Following Percutaneous Coronary InterventionThe American Journal of Cardiology, 2007
- Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non–ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trialAmerican Heart Journal, 2006